Amphista Therapeutics
Latest round
- Series B
Last raised
- Dec 2022
Total raised
- $54M
Investors
- 9
About Amphista Therapeutics
Founded in 2017 as a spin-out from Advent Life Sciences, founded by Alessio Ciulli, and based in Cambridge, UK, Amphista Therapeutics Limited operates as a biotechnology company that develops drugs and pharmaceuticals using targeted protein degradation (TPD).57 million post-money. Advent Life Sciences offers Proprietary EclipsysTM, a drug development platform for identifying new TPD mechanisms and optimizing bifunctional TPD therapies. The company’s platform targets a broad range of diseases in oncology, immunology, CNS disorders, and other areas capable of degrading proteins, including nuclear, cytosolic, and membrane-associated targets, enzymes, and epigenetic factors.
Who invested in Amphista Therapeutics
9 investors across 3 rounds
See all investors in Amphista Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Amphista Therapeutics
Who invested in Amphista Therapeutics?
Amphista Therapeutics has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amphista Therapeutics raised?
Amphista Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Amphista Therapeutics last raise money?
Amphista Therapeutics's most recent round on record is a Series B, in Dec 2022.
What does Amphista Therapeutics do?
Founded in 2017 as a spin-out from Advent Life Sciences, founded by Alessio Ciulli, and based in Cambridge, UK, Amphista Therapeutics Limited operates as a biotechnology company that develops drugs and pharmaceuticals using targeted protein degradation (TPD).
Where is Amphista Therapeutics headquartered?
Amphista Therapeutics is headquartered in Cambridge, UK.
Which VCs invest in companies like Amphista Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Amphista Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Amphista Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.